@article{b0e1916235954942a442db71c40b3781,
title = "Dear colleagues: enough with the men-only author panels",
keywords = "Authorship, Cardiovascular research, Disparities, Gender",
author = "\{Van Spall\}, \{Harriette G.C.\} and Roxana Mehran and Januzzi, \{James L.\}",
note = "Funding Information: Conflict of interest: J.L.J. is a Trustee of the American College of Cardiology, a Board member of Imbria Pharmaceuticals, has received grant support from Abbott Diagnostics, Applied Therapeutics, Innolife, Novartis Pharmaceuticals and Roche Diagnostics, consulting income from Abbott, Janssen, Novartis, Prevencio, and Roche Diagnostics, and participates in clinical endpoint committees/data safety monitoring boards for Abbott, AbbVie, Amgen, Bayer, CVRx, Janssen, MyoKardia, Takeda and Vifor. R.M. has received support from Abbott Laboratories, Abiomed, Applied Therapeutics, AstraZeneca, Bayer, Beth Israel Deaconess, Briston-Myers Squibb, CERC, Chiesi, Concept Medical, CSL Behring, DSI, and is co-founder of Women As One. H.G.C.V. receives research support from Canadian Institutes of Health Research and Heart and Stroke Foundation of Canada, and has initiated a Clinical Trials Diversity fellowship program to increase diversity among researchers.",
year = "2022",
month = dec,
day = "1",
doi = "10.1093/eurheartjsupp/suac118",
language = "English",
volume = "24",
pages = "L53--L56",
journal = "European Heart Journal, Supplement",
issn = "1520-765X",
publisher = "Oxford University Press",
number = "Sl",
}